Back to search
FDAFDA · Food and drugs·Recall number D-1535-2016

Papaverine 150 mg/Phentolamine 5 mg and Prostaglandin 50 mcg, packaged as 5.5 mL in a 10 mL MDV, Rx only, Vital Care Compounder, Hattiesburg, MS 39402

Published October 5, 2016 · Recall initiated: July 26, 2016

Summary

FDA records drug Class II recall D-1535-2016, published October 5, 2016 and initiated July 26, 2016. Recalling firm: Pharmacy Plus, Inc. dba Vital Care Compounder; Status: Terminated; Reported quantity: 386606 - 3 vials, 393302 - 3 vials; Lot: Lot#: 386606, Use by 8-9-16, 393302, Use by 10-28-16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmacy Plus, Inc. dba Vital Care Compounder
Distributor
MS
Lot
Lot#: 386606, Use by 8-9-16, 393302, Use by 10-28-16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Papaverine 150 mg/Phentolamine 5 mg and Prostaglandin 50 mcg, packaged as 5.5 mL in a 10 mL MDV, Rx only, Vital Care Compounder, Hattiesburg, MS 39402 recalled?

Yes. FDA published recall D-1535-2016 on October 5, 2016. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone